FDA Approves Rocklatan (netarsudil and latanoprost ophthalmic solution) for the Reduction of Intraocular Pressure in Open-Angle Glaucoma or Ocular Hypertension DURHAM, N.C.–(BUSINESS WIRE)–Mar. 12, 2019– Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, […]Continue Reading ...
(From left) Researchers Ted Allison, Tim Footz and Gavin Neil in Allison’s zebrafish lab at the University of Alberta. The trio worked with medical geneticist Michael Walter to discover a gene that causes a type of glaucoma that strikes young males. Credit: Jordan Carson An international team of researchers has identified a gene responsible for […]Continue Reading ...
Credit: CC0 Public Domain Glaucoma is characterized by degeneration of retinal ganglion cells, leading to irreversible vision loss. Currently, the only treatable glaucoma risk factor is increased intraocular pressure. While lowering this pressure can slow vision loss, it does not completely halt progression of the disease. Therefore, determining more direct mechanisms to prevent retinal cell […]Continue Reading ...
Glaucoma results in progressive damage to the optic nerve, the part of the eye that carries visual information from the eye to the brain. Credit: National Eye Institute The most common tests for glaucoma can underestimate the severity of the condition by not detecting the presence of central vision loss, according to a new Columbia […]Continue Reading ...
Purdue University researchers have invented a new smart drainage device to help patients with glaucoma, a leading cause of blindness in the world, as they try to save their eyesight. Glaucoma can be treated only with medications or surgical implants, both of which offer varying degrees of success in helping to improve sight and to […]Continue Reading ...
Researchers at Ruhr-Universität Bochum have identified new potential biomarkers that may facilitate early detection of glaucoma in patients. Moreover, they ascertained that the mutation of a certain gene in mice causes intraocular pressure elevation. This, in turn, is one of the main risk factors for glaucoma. The team headed by Dr. Jacqueline Reinhard and Prof. […]Continue Reading ...
Credit: CC0 Public Domain A research team from Massachusetts Eye and Ear and the Massachusetts Institute of Technology has shown that immune cells in the eye that developed in response to early exposure to bacteria are a key contributor to progressive vis8/9/2018ion loss from glaucoma, the second leading cause of irreversible blindness in the world. […]Continue Reading ...
August 12, 2018 A research team from Massachusetts Eye and Ear and the Massachusetts Institute of Technology has shown that immune cells in the eye that developed in response to early exposure to bacteria are a key contributor to progressive vision loss from glaucoma, the second leading cause of irreversible blindness in the world. The […]Continue Reading ...
The health burden of glaucoma has continuously increased around the globe in the past 25 years, according to an Acta Opthalmologica study. Higher burdens were associated with lower socioeconomic level and older age. In addition, being female and being exposed to higher ambient ultraviolet radiation and higher levels of air pollution were significantly associated with […]Continue Reading ...
Meditators and non-meditators had similar parameters before start of the study. After 3 weeks of meditation, there was significant lowering of intraocular pressure (IOP), cortisol and levels of oxidative stress, while there was an increase in brain-derived neurotrophic factors and beta endorphins with improvement in quality of life measures (QOL) in the meditators, while there […]Continue Reading ...
The most common tests for glaucoma can underestimate the severity of the condition because they do not detect the presence of central vision loss, ophthalmologists at Columbia have found.Continue Reading ...
The most common tests for glaucoma can underestimate the severity of the condition by not detecting the presence of central vision loss, according to a new Columbia University study. The study, published Nov. 8 in JAMA Ophthalmology, found that administering a variation of the visual field test that better assesses macular damage can improve diagnosis […]Continue Reading ...
Oct 12 2018 Fight for Sight has chosen World Sight Day 2018 (11 October) to announce funding for a research project that will develop personalized medicine for patients at risk of glaucoma from steroid use. Tom Beare was diagnosed with steroid induced glaucoma Professor Colin Willoughby from Ulster University has been awarded a £170,000 project […]Continue Reading ...
Smith had no symptoms of vision loss and went to her regular checkups, so she was devastated to learn that the doctor she had seen for years missed such an important diagnosis. She decided to look for another doctor who could help her get an official diagnosis and treatment. Fortunately for Smith, she worked as […]Continue Reading ...
August 10, 2018 A research team from Massachusetts Eye and Ear and MIT has shown that immune cells in the eye that developed in response to early exposure to bacteria are a key contributor to progressive vision loss from glaucoma, the second leading cause of irreversible blindness in the world. The findings, published online in […]Continue Reading ...
- Smell of skin could lead to early diagnosis for Parkinson’s
- Difference in brain connectivity may explain autism spectrum disorder
- Untangling the microbiome — with statistics
- Human microbiome metabolites enhance colon injury by enterohemorrhagic E. coli, study shows
- Written media can improve citizens’ understanding of palliative care
- New research aims to find how asthma symptoms are aggravated
- New $9.7 million NIH grant project seeks to improve hearing restoration
- Researchers measure brain metabolite levels in people with mild memory problems
- FDA approves first drug for treatment of postpartum depression in adult women
- Gene editing and designer babies experiments face global moratorium
- Major scientific study of wound care dressings wins ‘Best Clinical or Preclinical Research Award’
- Biohaven Enrolls First Patient In Phase 3 Generalized Anxiety Disorder (GAD) Trial Of Troriluzole
- Big data study identifies drugs that increase risk of psychosis in youth with ADHD
- Mystery novel and dream spur key scientific insight into heart defect | News Center
- Study measures impact of policies designed to reduce air pollution in two mega-cities
- Mild sleep apnea during pregnancy changes sugar levels and may affect infant growth patterns
- SSB and Novasep collaborate to develop new membrane chromatography systems
- Leaky valve repair improves quality of life in heart failure patients
- Diattenuation Imaging offers structural information of difficult to access brain regions
- Early sports specialization linked to increased injury rates during athletic career